Skip to content

Long-term clinical curative effect and survival quality of advanced unresectable gastric cancer after stomach partitioning gastrojejunostomy (SPGJ) Roux-en-Y:A prospective controlled clinical trial to study

Long-term clinical curative effect and survival quality of advanced unresectable gastric cancer after stomach partitioning gastrojejunostomy (SPGJ) Roux-en-Y:A prospective controlled clinical trial to study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17010766
Enrollment
Unknown
Registered
2017-03-03
Start date
2017-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal tumor

Interventions

Group R:stomach partitioning gastrojejunostomy (SPGJ) Roux-en-Y
Group B:stomach partitioning gastrojejunostomy (SPGJ) Billroth-II

Sponsors

Affiliated Hospital of Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) aged less than 80 years; 2) All patients were diagnosed with gastric cancer before operation; 3) According to the clinical stage and preoperative CT examination, all patients were considered as stage III and IV, and the CT scan showed that the tumors could not be resected; 4) the patient's condition can be tolerated.

Exclusion criteria

Exclusion criteria: (1) refusing to participate in the study; (2) can not perform the preoperative neuropsychological tests; (3) associated with other malignancies; (4) the presence of unresectable distant metastases; (5) associated with the impact of diabetes and other systemic disease after recovery; (6) preoperative radiotherapy and chemotherapy patients

Design outcomes

Primary

MeasureTime frame
Postoperative recovery related data: (1) exhaust time; (2) liquid feeding time. 3. Eating semifluid time; (4) of bed activity time; (5) postoperative hospital stay, 6. The total cost;Postoperative follow-up;Postoperative complications: (1) wound infection; (2) the abdominal cavity infection; (3) anastomotic bleeding; (4) reoperation rate; (5) anastomotic fistula;ata related to the operation: (1) operation time; (2) identical time; (3) intraoperative bleeding; (4) tumor size;

Countries

China

Contacts

Public ContactXianxiang Zhang

Affiliated Hospital of Qingdao University

xianxiang1115@163.com+86 18661802636

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026